M Decruyenaere
Overview
Explore the profile of M Decruyenaere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Depuydt O, Daeze C, Benoit D, Praet M, Vermassen E, Decruyenaere M
Anaesth Intensive Care
. 2013 Aug;
41(5):610-7.
PMID: 23977912
Acute respiratory failure with bilateral pulmonary infiltrates is a clinical problem with a wide differential diagnosis. We evaluated whether open lung biopsy offered a diagnosis and therapeutic guidance in cases...
2.
Mularczyk E, Decruyenaere M, Denayer L, Evers-Kiebooms G
Genet Couns
. 2008 Feb;
18(4):367-78.
PMID: 18286817
Because of the burden of serious late onset hereditary diseases, psychological counselling is commonly included in the predictive testing procedure. We discuss the components of psychological counselling in the context...
3.
Claes E, Evers-Kiebooms G, Denayer L, Decruyenaere M, Boogaerts A, Philippe K, et al.
J Genet Couns
. 2005 Oct;
14(5):349-63.
PMID: 16195942
This prospective study evaluates emotional functioning and illness representations in 68 unaffected women (34 carriers/34 noncarriers) 1 year after predictive testing for BRCA1/2 mutations when offered within a multidisciplinary approach....
4.
Hopwood P, van Asperen C, Borreani G, BOURRET P, Decruyenaere M, Dishon S, et al.
Community Genet
. 2004 Aug;
6(4):192-205.
PMID: 15331865
Objective: To conduct a survey in seven European cancer genetics centres to compare service provision, organisation and practices for familial breast and colon cancer consultations and testing. Information was obtained...
5.
Decruyenaere M, Evers-Kiebooms G, Denayer L, Welkenhuysen M
Community Genet
. 2004 Jun;
1(1):23-35.
PMID: 15178984
The first aim of the paper is to review research into the uptake of carrier testing for cystic fibrosis and into the impact of carrier testing on self-esteem, risk perception...
6.
Decruyenaere M, Evers-Kiebooms G, Cloostermans T, Boogaerts A, Demyttenaere K, Dom R, et al.
Clin Genet
. 2004 Mar;
65(1):24-31.
PMID: 15032971
This study focuses on the partner relationship of tested persons, 5 years after their predictive test result for Huntington's disease (HD). We describe changes in marital status, quality of the...
7.
Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R
Acta Neurol Scand
. 2002 Aug;
106(3):131-41.
PMID: 12174172
Objectives: To determine (1) whether the battery of neuropsychological tests was sufficiently sensitive to find differences between symptomatic patients with Huntington's disease (HD) and clinically asymptomatic individuals carrying the HD...
8.
Welkenhuysen M, Evers-Kiebooms G, Decruyenaere M, Claes E, Denayer L
J Med Genet
. 2001 Aug;
38(8):540-7.
PMID: 11494966
No abstract available.
9.
Evers-Kiebooms G, Nys K, Decruyenaere M, Witters I
Community Genet
. 2001 Aug;
4(1):43-49.
PMID: 11493752
Objectives: It was the main aim of the present retrospective study carried out in Flanders to evaluate how women with a false-positive triple test result look back on their experience...
10.
Decruyenaere M, Evers-Kiebooms G, Welkenhuysen M, Denayer L, Claes E
Psychooncology
. 2001 Feb;
9(6):528-36.
PMID: 11180588
Individuals at high risk for developing breast and/or ovarian cancer are faced with difficult decisions regarding genetic testing, cancer prevention and/or intensive surveillance. Large interindividual differences exist in the uptake...